Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / Urine as a Cancer 'Biopsy'?
Oncology Liquid biopsy Screening and monitoring Research and Innovations

Urine as a Cancer ‘Biopsy’?

Study traces tumor-derived extracellular vesicles from blood to urine through glomerular transport

03/18/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Oncology and Molecular Diagnostics

Leading institutions in oncology, molecular diagnostics, and nephrology employ advanced molecular biology techniques, in vivo imaging, and translational research to elucidate mechanisms of EV trafficking and develop urine-based cancer biomarkers.

  • #1

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC is a world leader in cancer research and liquid biopsy development, with extensive expertise in extracellular vesicle biology and translational oncology.

    Key Differentiators

    • Oncology
    • Molecular Diagnostics
    • Cancer Biology
  • #2

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins has a robust track record in cancer biomarker discovery and kidney physiology research, supporting studies on EV trafficking and urine-based diagnostics.

    Key Differentiators

    • Oncology
    • Nephrology
    • Molecular Biology
  • #3

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber is renowned for its innovative cancer research programs, including the development of noninvasive diagnostic tools such as urine-based liquid biopsies.

    Key Differentiators

    • Oncology
    • Molecular Diagnostics
    • Cancer Research
  • #4

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF combines expertise in kidney biology and cancer diagnostics, contributing to understanding EV transport mechanisms and biomarker validation in urine.

    Key Differentiators

    • Oncology
    • Nephrology
    • Molecular Medicine
  • #5

    Mayo Clinic

    Rochester, MN

    Mayo Clinic integrates clinical and translational research in oncology and nephrology, advancing urine-based biomarker discovery and validation for cancer diagnostics.

    Key Differentiators

    • Oncology
    • Nephrology
    • Translational Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.